- Home
- VRTX vs UNP Comparison
VRTX vs UNP Comparison
Compare VRTX & UNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTX
- UNP
- Stock Information
- Founded
- VRTX 1989
- UNP 1862
- Country
- VRTX United States
- UNP United States
- Employees
- VRTX N/A
- UNP N/A
- Industry
- VRTX EDP Services
- UNP Railroads
- Sector
- VRTX Technology
- UNP Industrials
- Exchange
- VRTX Nasdaq
- UNP Nasdaq
- Market Cap
- VRTX 115.6B
- UNP 130.8B
- IPO Year
- VRTX 1991
- UNP N/A
- Fundamental
- Price
- VRTX $445.37
- UNP $230.38
- Analyst Decision
- VRTX Buy
- UNP Buy
- Analyst Count
- VRTX 26
- UNP 21
- Target Price
- VRTX $510.48
- UNP $255.38
- AVG Volume (30 Days)
- VRTX 1.3M
- UNP 3.2M
- Earning Date
- VRTX 07-31-2025
- UNP 07-24-2025
- Dividend Yield
- VRTX N/A
- UNP 2.33%
- EPS Growth
- VRTX N/A
- UNP 6.03
- EPS
- VRTX N/A
- UNP 11.10
- Revenue
- VRTX $11,099,700,000.00
- UNP $24,246,000,000.00
- Revenue This Year
- VRTX $10.48
- UNP $2.02
- Revenue Next Year
- VRTX $10.69
- UNP $4.44
- P/E Ratio
- VRTX N/A
- UNP $20.72
- Revenue Growth
- VRTX 8.98
- UNP 0.63
- 52 Week Low
- VRTX $377.85
- UNP $204.66
- 52 Week High
- VRTX $519.88
- UNP $258.07
- Technical
- Relative Strength Index (RSI)
- VRTX 45.87
- UNP 60.22
- Support Level
- VRTX $436.81
- UNP $225.47
- Resistance Level
- VRTX $451.88
- UNP $228.03
- Average True Range (ATR)
- VRTX 9.25
- UNP 2.82
- MACD
- VRTX 0.32
- UNP 0.56
- Stochastic Oscillator
- VRTX 28.02
- UNP 92.73
About VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the US, Union Pacific generated $24 billion of revenue in 2024 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.